<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">46087</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2025-29-3-321-334</article-id><article-id pub-id-type="edn">POWVSY</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ONCOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОНКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Elemental homeostasis in children and adolescents after completion of antitumor therapy for malignant neoplasms</article-title><trans-title-group xml:lang="ru"><trans-title>Элементный гомеостаз у детей и подростков после завершения противоопухолевой терапии злокачественных новообразований</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6899-7105</contrib-id><contrib-id contrib-id-type="spin">8225-6360</contrib-id><name-alternatives><name xml:lang="en"><surname>Zhukovskaya</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Жуковская</surname><given-names>Е. В.</given-names></name></name-alternatives><email>lobaeva.t@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5677-1141</contrib-id><contrib-id contrib-id-type="spin">9151-0950</contrib-id><name-alternatives><name xml:lang="en"><surname>Lobaeva</surname><given-names>Tatiana A.</given-names></name><name xml:lang="ru"><surname>Лобаева</surname><given-names>Т. А.</given-names></name></name-alternatives><email>lobaeva.t@yandex.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4664-5616</contrib-id><name-alternatives><name xml:lang="en"><surname>Karelin</surname><given-names>Alexander F.</given-names></name><name xml:lang="ru"><surname>Карелин</surname><given-names>А. Ф.</given-names></name></name-alternatives><email>lobaeva.t@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1373-6354</contrib-id><contrib-id contrib-id-type="spin">7764-6486</contrib-id><name-alternatives><name xml:lang="en"><surname>Korobeynikova</surname><given-names>Tatiana V.</given-names></name><name xml:lang="ru"><surname>Коробейникова</surname><given-names>Т. В.</given-names></name></name-alternatives><email>lobaeva.t@yandex.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1643-5960</contrib-id><contrib-id contrib-id-type="spin">2227-6305</contrib-id><name-alternatives><name xml:lang="en"><surname>Rumyantsev</surname><given-names>Alexander G.</given-names></name><name xml:lang="ru"><surname>Румянцев</surname><given-names>А. Г.</given-names></name></name-alternatives><email>lobaeva.t@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7838-1366</contrib-id><contrib-id contrib-id-type="spin">5231-9017</contrib-id><name-alternatives><name xml:lang="en"><surname>Skalny</surname><given-names>Anatoly V.</given-names></name><name xml:lang="ru"><surname>Скальный</surname><given-names>А. В.</given-names></name></name-alternatives><email>lobaeva.t@yandex.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology</institution></aff><aff><institution xml:lang="ru">Научный центр медицины и реабилитации «Русское поле», Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">RUDN University</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">MGIMO-MED Medical University</institution></aff><aff><institution xml:lang="ru">Медицинский университет МГИМО-МЕД</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-09-25" publication-format="electronic"><day>25</day><month>09</month><year>2025</year></pub-date><volume>29</volume><issue>3</issue><issue-title xml:lang="en">ONCOLOGY</issue-title><issue-title xml:lang="ru">ОНКОЛОГИЯ</issue-title><fpage>321</fpage><lpage>334</lpage><history><date date-type="received" iso-8601-date="2025-09-25"><day>25</day><month>09</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Zhukovskaya E.V., Lobaeva T.A., Karelin A.F., Korobeynikova T.V., Rumyantsev A.G., Skalny A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Жуковская Е.В., Лобаева Т.А., Карелин А.Ф., Коробейникова Т.В., Румянцев А.Г., Скальный А.В.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Zhukovskaya E.V., Lobaeva T.A., Karelin A.F., Korobeynikova T.V., Rumyantsev A.G., Skalny A.V.</copyright-holder><copyright-holder xml:lang="ru">Жуковская Е.В., Лобаева Т.А., Карелин А.Ф., Коробейникова Т.В., Румянцев А.Г., Скальный А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/46087">https://journals.rudn.ru/medicine/article/view/46087</self-uri><abstract xml:lang="en"><p>Relevance. As medical research develops, more and more attention is being paid to the study of elemental changes in cancer patients not only as a marker of the disease, but also as a possible complication of the disease. The aim was to study changes in the level of essential and toxic trace elements in patients who have undergone antitumor therapy (AT) for malignant neoplasms (MN). Materials and Methods. As part of a retrospective monocenter study, a group of 214 patients from the Russian Field Medical and Rehabilitation Research Center aged 4 to 17 years was formed. All patients were in remission after the completion of antitumor treatment: 107 patients with hemoblastosis and 107 with solid tumors. The age of the participants ranged from 4.2 to 17.6 years, with an average age of 11.4 years. For a comprehensive assessment of the elemental status in children, hair and blood serum were used, measurements were carried out by mass spectrometry after mineralization of the samples. Results and Discussion. The results of the study of hair samples and blood serum showed that the elemental profile of patients after AT has both similar patterns and distinctive features depending on the histological type of tumor. Conclusions. Patients with solid tumors had a higher accumulation of toxic metals compared to samples taken from patients with tumors of the hematopoiesis organs. Nevertheless, no serious specific changes in elemental homeostasis were observed depending on the histological structure. The results obtained emphasize the importance of careful monitoring of homeostasis parameters to prevent the development of complications of antitumor therapy associated with elemental homeostasis.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность. По мере развития медицинских исследований все больше внимания уделяется изучению элементных изменений у онкологических больных не только как маркера заболевания, но и как возможного осложнения заболевания. Целью данного исследования является изучение изменений уровня эссенциальных и токсичных микроэлементов у пациентов, прошедших противоопухолевую терапию (ПОТ) по поводу злокачественных новообразований (ЗНО). Материалы и методы. В рамках проведения ретроспективного моноцентрового исследования была сформировано группа из 214 пациентов лечебно-­реабилитационного научного центра “Русское поле” в возрасте от 4 до 17 лет. Все пациенты находились в состоянии ремиссии после завершения противоопухолевого лечения: 107 человек — по поводу гемобластозов и 107 — солидных опухолей. Возраст участников составлял от 4,2 до 17,6 лет, средний возраст — 11,4 года. Для комплексной оценки элементного статуса у детей использованы биосубстраты (волосы и сыворотка крови), измерения проводили методом масс-спектрометрии после минерализации образцов. Результаты и обсуждение. Результаты исследования образцов волос и сыворотки крови показали, что элементный профиль пациентов после ПОТ имеет как сходные закономерности, так и отличительные особенности в зависимости от гистологического типа опухоли. Выводы. Наши данные показывают, что у пациентов с солидными опухолями наблюдалось более высокое накопление токсичных металлов по сравнению с образцами, взятыми у пациентов с опухолями органов кроветворения. Тем не менее, серьезных специфических изменений элементного гомеостаза в зависимости от гистологической структуры не наблюдалось. Полученные результаты подчеркивают важность тщательного мониторинга параметров гомеостаза для предотвращения развития осложнений противоопухолевой терапии, связанных с элементным гомеостазом.</p></trans-abstract><kwd-group xml:lang="en"><kwd>trace elements</kwd><kwd>macronutrients</kwd><kwd>essential elements</kwd><kwd>toxic elements</kwd><kwd>the element status</kwd><kwd>elemental imbalance</kwd><kwd>carcinogenesis</kwd><kwd>solid tumors</kwd><kwd>tumors of the hematopoiesis system</kwd><kwd>hair</kwd><kwd>the serum</kwd><kwd>late effects</kwd><kwd>inductively coupled plasma mass spectrometry</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>микроэлементы</kwd><kwd>макроэлементы</kwd><kwd>эссенциальные элементы</kwd><kwd>токсичные элементы</kwd><kwd>элементный статус</kwd><kwd>элементный дисбаланс</kwd><kwd>канцерогенез</kwd><kwd>солидные опухоли</kwd><kwd>опухоли системы кроветворения</kwd><kwd>волосы</kwd><kwd>сыворотка</kwd><kwd>поздние эффекты</kwd><kwd>масс-спектрометрия с индуктивно связанной плазмой</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Работа профинансирована Министерством науки и высшего образования Российской Федерации в рамках государственной поддержки создания и развития исследовательских центров мирового уровня «Цифровой биодизайн и персонализированное здравоохранение» № 075-15-2022-304.</institution></institution-wrap><institution-wrap><institution xml:lang="en">This work was funded by the Ministry of Science and Higher Education of the Russian Federation as part of state support for the creation and development of world-­class research centers “Digital Biodesign and Personalized Healthcare” No. 075-15-2022-304.</institution></institution-wrap></funding-source></award-group></funding-group></article-meta><fn-group/></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007;121(11):2381–2386. doi.org/10.1002/ijc.23192</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kolachi NF, Kazi TG, Afridi HI, Kazi NG, Khan S. Investigation of essential trace and toxic elements in biological samples (blood, serum and scalp hair) of liver cirrhotic/cancer female patients before and after mineral supplementation. Clin Nutr. 2012;31 (6):967–973. doi.org/10.1016/j.clnu.2012.04.015</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lossow K, Schwarz M, Kipp AP. Are trace element concentrations suitable biomarkers for the diagnosis of cancer? Redox Biol. 2021;42:101900. doi.org/10.1016/j.redox.2021.101900</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Wach S, Weigelt K, Michalke B. Diagnostic potential of major and trace elements in the serum of bladder cancer patients. J Trace Elem Med Biol. 2018;46:150–155. doi.org/10.1016/j.jtemb.2017.12.010</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Jouybari L, Saei Ghare Naz M, Sanagoo A. Toxic elements as biomarkers for breast cancer: a meta-analysis study. Cancer Manag Res. 2018;10:69–79. doi.org/10.2147/CMAR.S151324</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Cobanoglu U, Demir H, Sayi, F, Duran M, Mergan D. Some mineral, trace element and heavy metal concentrations in lung cancer. Asian Pacific journal of cancer prevention: APJCP. 2010;11(5),1383–1388.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hsu MY, Mina E, Roetto A, Porporato PE. Iron: An Essential Element of Cancer Metabolism. Cells. 2020;9(12):2591. doi.org/10.3390/cells9122591</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kuršvietienė L, Mongirdienė A, Bernatonienė J, Šulinskienė J, Stanevičienė I. Selenium Anticancer Properties and Impact on Cellular Redox Status. Antioxidants (Basel). 2020;9(1):80. doi.org/10.3390/antiox9010080</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Zabłocka-­Słowińska K, Płaczkowska S, Prescha A, et al. Serum and whole blood Zn, Cu and Mn profiles and their relation to redox status in lung cancer patients. J Trace Elem Med Biol. 2018;45:78–84. doi.org/10.1016/j.jtemb.2017.09.024</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Zeng H. Selenium as an essential micronutrient: roles in cell cycle and apoptosis. Molecules. 2009;14(3):1263–1278. https://doi.org/10.3390/molecules14031263</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hayes JD, Dinkova-­Kostova AT, Tew KD. Oxidative Stress in Cancer. Cancer Cell. 2020;38(2):167–197. doi.org/10.1016/j.ccell.2020.06.001</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Zhukovskaya EV, Savko SA, Obukhov YA, Karelin AF, Goncharov AP, Zhernov YV, Skalny AV. Serum levels of chemical elements and carious lesions in children after antitumor therapy. Sechenov Medical Journal. 2023;13(4):45–55. doi.org/10.47093/2218-7332.2022.13.4.45-55</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ahmadi N, Mahjoub S, Haji Hosseini R, TaherKhani M, Moslemi D. Alterations in serum levels of trace element in patients with breast cancer before and after chemotherapy. Caspian J Intern Med. 2018;9(2):134–139. doi.org/10.22088/cjim.9.2.134</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Ruiz-­Ramos R, Lopez-­Carrillo L, Rios-­Perez AD, De Vizcaya-­Ruíz A, Cebrian ME. Sodium arsenite induces ROS generation, DNA oxidative damage, HO‑1 and c-­Myc proteins, NF-kappaB activation and cell proliferation in human breast cancer MCF‑7 cells. Mutat Res. 2009;674(1–2):109–115. doi.org/10.1016/j.mrgentox.2008.09.021</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Saikawa H, Nagashima H, Cho K, et al. Relationship between Trace Element in Tumor and Prognosis in Lung Cancer Patients. Medicina (Kaunas). 2021;57(3):209. doi.org/10.3390/medicina57030209</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Samavarchi Tehrani S, Mahmoodzadeh Hosseini H, Yousefi T. The crosstalk between trace elements with DNA damage response, repair, and oxidative stress in cancer. J Cell Biochem. 2019;120(2):1080–1105. doi.org/10.1002/jcb.27617</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yang YW, Dai CM, Chen XH, Feng JF. The Relationship between Serum Trace Elements and Oxidative Stress of Patients with Different Types of Cancer. Oxid Med Cell Longev. 2021;2021:4846951. doi.org/10.1155/2021/4846951</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi.org/10.1016/j.cell.2011.02.013</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Voorzanger-­Rousselot N, Garnero P. Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses. Cancer Treat Rev. 2007;33(3):230–283. doi.org/10.1016/j.ctrv.2007.01.008</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Seiki M. The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol. 2002;14(5):624–632. doi.org/10.1016/s0955-0674 (02) 00363-0</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Shahbaz U, Yu X bin. An analysis of brain tumor trace elements and their effects. Trace Elements and Electrolytes. 2022;39(01):32–42. doi.org/10.5414/tex01680</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Nawi AM, Chin SF, Azhar Shah S, Jamal R. Tissue and Serum Trace Elements Concentration among Colorectal Patients: A Systematic Review of Case-­Control Studies. Iran J Public Health. 2019;48(4):632–643.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Azin F, Raie RM, Mahmoudi MM. Correlation between the levels of certain carcinogenic and anticarcinogenic trace elements and esophageal cancer in northern Iran. Ecotoxicol Environ Saf. 1998;39(3):179–184. doi.org/10.1006/eesa.1997.1601</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Mulware S.J. Trace elements and carcinogenicity: a subject in review. 3 Biotech. 2013;3(2), 85–96. doi.org/10.1007/s13205-012-0072-6</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Goldhaber, S.B. Trace element risk assessment: essentiality vs. toxicity. Regulatory toxicology and pharmacology. 2003;38(2):232–242.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Silvera SAN, Rohan TE. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes &amp; Control. 2007;18, 7–27.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Chen F, Vallyathan V, Castranova V, Sh, X. Cell apoptosis induced by carcinogenic metals. Molecular and Cellular Biochemistry. 2001;222, 183–188.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Klotz K, Weistenhöfer W, Neff F, Hartwig A, van Thriel C, Drexler H. The Health Effects of Aluminum Exposure. Dtsch Arztebl Int. 2017;114(39):653–659. doi:10.3238/arztebl.2017.0653</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Galván-­Arzate S, Santamarı́a A. Thallium toxicity. Toxicology letters, 1998;99(1):1–13.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Genchi G, Carocci A, Lauria G, Sinicrop, MS, Catalano A. Thallium use, toxicity, and detoxification therapy: An overview. Applied Sciences. 2021;11(18):8322.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Hernandez-­Delgadillo R, García-­Cuéllar CM, Sánchez-­Pérez Y, Pineda-­Aguilar N, Martínez-­Martínez MA., Rangel-­Padilla EE. Cabral-­Romero C. In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells. International Journal of Nanomedicine. 2018;6089–6097.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Collin MS, Venkatraman SK, Vijayakumar N, Kanimozhi V, Arbaaz SM, Stacey RS, Swamiappan S. Bioaccumulation of lead (Pb) and its effects on human: A review. Journal of Hazardous Materials Advances. 2022;7:100094.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Hollins DM, McKinley MA, Williams C, et al. Beryllium and lung cancer: a weight of evidence evaluation of the toxicological and epidemiological literature. Crit Rev Toxicol. 2009;39(Suppl 1):1–32. doi.org/10.1080/10408440902837967</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Verougstraete V, Lison D, Hotz P. Cadmium, lung and prostate cancer: a systematic review of recent epidemiological data. J Toxicol Environ Health B Crit Rev. 2003;6(3):227–255. doi.org/10.1080/10937400306465</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Hartwig A. Cadmium and cancer. Met Ions Life Sci. 2013;11:491–507. doi.org/10.1007/978-94-007-5179-8_15</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Chrysochou E, Koukoulakis K, Kanellopoulos PG, et al. Human serum elements’ levels and leukemia: A first pilot study from an adult Greek cohort. J Trace Elem Med Biol. 2021;68:126833. doi.org/10.1016/j.jtemb.2021.126833</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Lu H, Shi X, Costa M, Huang C. Carcinogenic effect of nickel compounds. Mol Cell Biochem. 2005;279(1–2):45–67. doi.org/10.1007/s11010-005-8215-2</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Yu M, Zhang J. Serum and hair nickel levels and breast cancer: systematic review and meta-analysis Biological Trace Element Research. 2017;179:32–37.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Moussa RS, Park KC, Kovacevic Z, Richardson DR. Ironing out the role of the cyclin-­dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity. Free Radic Biol Med. 2019;133:276–294. doi.org/10.1016/j.freeradbiomed.2018.03.027</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chemical research in toxicology. 2008;21(1):28–44.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Kaczmarek M, Timofeeva O A, Karaczyn A, Malyguine A, Kasprzak KS, Salnikow K. The role of ascorbate in the modulation of HIF‑1alpha protein and HIF-dependent transcription by chromium (VI) and nickel (II) Free Radical Biol. Med. 2007;42:1246–1257.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Davidson T, Chen H, Garrick MD, D’Angelo G, Costa M. Soluble nickel interferes with cellular iron homeostasis Mol. Cell. Biochem. 2005;279:157–162</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer science. 2009;100(1):9–16.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Pandrangi SL, Chittineedi P, Chikati R, Lingareddy JR, Nagoor M, Ponnada SK. Role of dietary iron revisited: In metabolism, ferroptosis and pathophysiology of cancer. American Journal of Cancer Research. 2022;12(3):974.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Caroline L, Rosner F, Kozinn P J. Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia. Blood, 1969;34(4):441–451.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Kim S, Freeland-­Graves JH, Babaei M, Sachdev PK, Beretvas SN. Quantifying the association between acute leukemia and serum zinc, copper, and selenium: a meta-analysis. Leuk Lymphoma. 2019;60(6):1548–1556. doi.org/10.1080/10428194.2018.15400 43</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev. 2009;35(1):32–46. doi.org/10.1016/j.ctrv.2008.07.004</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Li Y, Lou J, Hong S, Hou D, Lv Y, Guo Z, Liu H. The role of heavy metals in the development of colorectal cancer. BMC cancer. 2023;23(1):616.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Bishayee A. Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Letters. 2010;294 (1):1–12.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Léonard A, Gerber GB. Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat Res. 1994;317(1):81–88. doi.org/10.1016/0165-1110 (94) 90013-2</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Ścibior A, Pietrzyk Ł, Plewa Z, Skiba A. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-­applications with a summary of further research trends. J Trace Elem Med Biol. 2020;61:126508. doi:10.1016/j.jtemb.2020.126508</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Barranco WT, Eckhert CD. Boric acid inhibits human prostate cancer cell proliferation. Cancer letters. 2004;216(1):21–29.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Cebeci E, Yüksel B, Şahin F. Anti-cancer effect of boron derivatives on small-cell lung cancer. Journal of Trace Elements in Medicine and Biology. 2022;70:126923.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Cheng L, Sonntag DM, de Boer J, Dixon K. Chromium (VI)-induced mutagenesis in the lungs of big blue transgenic mice J. Environ. Pathol. Toxicol. Oncol. 2000;19:239–249.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Zekavat OR, Karimi M, Majidi F, Bordbar M, Haghpanah S, Parand S, Bozorgi H. Trace elements in children with acute lymphoblastic leukemia. Asian Pacific Journal of Cancer Prevention. 2021;22(S1):43–47.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Diez M, Arroyo M, Cerdan FJ. Serum and tissue trace metal levels in lung cancer. Oncology. 1989;6:230–4.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Rozenberg JM, Kamynina M, Sorokin M, Zolotovskaia M, Koroleva E, Kremenchutckaya K, Borisov N. The role of the metabolism of zinc and manganese ions in human cancerogenesis. Biomedicines. 2022;10(5):1072.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>De la Vieja A, Santisteban P. Role of iodide metabolism in physiology and cancer. Endocrine-­related cancer. 2018;25(4): R225-R245.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Balogová M, Sharma S, Cherek P, Ólafsson SN, Jónsdóttir S, Ögmundsdóttir HM, Damodaran KK. Cytotoxic effects of halogenated tin phosphinoyldithioformate complexes against several cancer cell lines. Dalton Transactions. 2022;51(34):13119–13128.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Cao GH, Yan SM, Yuan ZK, Wu L. Liu YF. A study of the relationship between trace element Mo and gastric cancer. World journal of gastroenterology. 1998;4(1):55.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Odularu AT, Ajibade PA, Mbese JZ. Impact of molybdenum compounds as anticancer agents. Bioinorganic chemistry and applications. 2019. doi: 10.1155/2019/6416198</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Yetişgin F, Bilici M, Esen R. Evaluation of Serum Levels of Trace Elements in Myeloproliferative Neoplasms: A Case-­Control Study. Eastern Journal of Medicine. 2021;26(2):344–350. doi: 10.5505/ejm.2021.58751</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>De Boeck M, Kirsch-­Volders M, Lison D. Cobalt and antimony: genotoxicity and carcinogenicity. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2003;533(1–2):135–152.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Wang X, Liang Z, Guo J, Wang M, Zhu R, Li Y, Ren Z. Metal/metalloid levels and variation in lifetime cancer risks among tissues. Human and Ecological Risk Assessment: An International Journal. 2021;27(2):504–516.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Wang J, Huang P, Lang C, Luo Y, He Z, Chen Y. The progress in the relationship between trace elements and acute lymphoblastic leukemia. Frontiers in Cell and Developmental Biology. 2023;11:1145563.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Kang M, Zhao L, Ren M, Deng M, Li C. Reduced metallothionein expression induced by Zinc deficiency results in apoptosis in hepatic stellate cell line LX‑2. Int. J. Clin. Exp. Med. 2025;8:20603–20609.</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Khan SU, Fatima K, Aisha S, Hamza B, Malik F. Redox balance and autophagy regulation in cancer progression and their therapeutic perspective. Med Oncol. 2022;40(1):12. doi.org/10.1007/s12032–022–01871–0</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal. 2008;10(8):1343–1374. doi.org/10.1089/ars.2007.1957</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Wallenberg M, Misra S, Wasik AM. Selenium induces a multi-­targeted cell death process in addition to ROS formation. J Cell Mol Med. 2014;18(4):671–684. doi.org/10.1111/jcmm.12214</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Ozgen IT, Dagdemir A, Elli M. Hair selenium status in children with leukemia and lymphoma. J Pediatr Hematol Oncol. 2007;29(8):519–522. doi.org/10.1097/MPH.0b013e3180f61b3a</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Evans SO, Khairuddin PF, Jameson MB. Optimising Selenium for Modulation of Cancer Treatments. Anticancer Res. 2017;37(12):6497–6509. doi.org/10.21873/anticanres.12106</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Wang J, Huang P, Lang C, Luo Y, He Z, Chen Y. The progress in the relationship between trace elements and acute lymphoblastic leukemia. Front Cell Dev Biol. 2023;11:1145563. doi.org/10.3389/fcell.2023.1145563</mixed-citation></ref><ref id="B73"><label>73.</label><citation-alternatives><mixed-citation xml:lang="en">Radzhabadiev RM, Evstratova VS, Solntseva TN. Evaluation of chemical composition and energy value of of the diets of highly skilled athletes. RUDN Journal of Medicine. 2018; 22(1):106–119. doi: 10.22363/2313-0245-2018-22-1-106-119. (In Russian).</mixed-citation><mixed-citation xml:lang="ru">Раджабкадиев Р.М., Евстратова В.С., Солнцева Т.Н. Оценка химического состава и энергетической ценности рационов питания высококвалифицированных спортсменов // Вестник Российского университета дружбы народов. Серия: Медицина. 2018. Т. 22. С. 106–119.</mixed-citation></citation-alternatives></ref><ref id="B74"><label>74.</label><citation-alternatives><mixed-citation xml:lang="en">Gedulyanov MT, Kiyaeva EV. Trace elements content in the hair of patients at the maxillofacial surgery department. RUDN Journal of Medicine. 2022;26(1):42–50. doi: 10.22363/2313-0245-2022-26-1-42-50. (In Russian).</mixed-citation><mixed-citation xml:lang="ru">Гедулянов МТ, Кияева ЕВ. Содержание микроэлементов в волосах пациентов отделения челюстно-­лицевой хирургии Вестник Российского университета дружбы народов. Серия: Медицина. 2022;26(1):42–50. doi: 10.22363/2313-0245-2022-26-1-42-50.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
